Tesamorelin
Tesamorelin from HG Wellness Peptides is produced for research programs examining hypothalamic-pituitary axis regulation, metabolic signaling pathways, and tissue-related metabolic processes. As a growth hormone-releasing hormone analog, it is suited for controlled studies investigating GH pulsatility and downstream metabolic and musculoskeletal signaling.
The peptide is manufactured in U.S. GMP-guided facilities, purified using modern chromatographic workflows, and then confirmed by independent HPLC and MS testing. Each batch receives a unique lot identifier and a fully documented Certificate of Analysis, allowing precise reference to purity and identity in experimental write-ups.
Supplied as a lyophilized powder, Tesamorelin supports stable storage conditions and consistent reconstitution across experimental workflows.
This product is designated for Research Use Only and is not intended for human or veterinary use.
Disclaimer
All products offered by HG Wellness Peptides are strictly intended for laboratory, scientific, and research purposes only. They are NOT for human consumption, clinical use, veterinary application, diagnostic procedures, or direct administration of any kind.
None of the statements on this website have been evaluated or approved by the U.S. Food and Drug Administration (FDA). These products are not medical devices, supplements, or drugs, and are not intended to diagnose, treat, cure, or prevent any disease, condition, or physical ailment.
By purchasing from this website, the buyer acknowledges and agrees that they are at least 21 years of age and are fully qualified, trained, and equipped to handle research chemicals in accordance with applicable laws, health, and safety protocols. HG Wellness Peptides assumes no liability for any direct, indirect, or consequential damages resulting from improper handling, misuse, or unauthorized application of these products.
Reach Out Anytime
Send questions about peptides, orders, or documentation, and our team responds promptly with clear, evidence-based guidance.